05140 |
Leishmaniasis |
9 |
5.61E-10 |
IL-10, IL-1A, TGFB1, NCF1, NOS2, STAT1, MAPK1, PTGS2, TNF
|
05200 |
Pathways in cancer |
13 |
5.36E-08 |
GSK3B, TGFB1, NOS2, PRKCB, STAT1, MMP1, MMP2, PTGS2, CCND1, MYC, BCL2, MAPK1, PPARD
|
05161 |
Hepatitis B |
8 |
2.75E-06 |
TGFB1, CCND1, STAT1, PRKCB, MYC, BCL2, MAPK1, TNF
|
05210 |
Colorectal cancer |
6 |
7.16E-06 |
GSK3B, TGFB1, CCND1, MYC, BCL2, MAPK1
|
05145 |
Toxoplasmosis |
7 |
7.75E-06 |
IL-10, TGFB1, NOS2, STAT1, BCL2, MAPK1, TNF
|
04919 |
Thyroid hormone signaling pathway |
7 |
1.00E-05 |
GSK3B, CCND1, STAT1, PRKCB, MYC, MAPK1, ESR1
|
05152 |
Tuberculosis |
8 |
1.03E-05 |
IL-10, IL-1A, TGFB1, NOS2, STAT1, BCL2, MAPK1, TNF
|
05133 |
Pertussis |
6 |
1.83E-05 |
IL-10, IL-1A, NOS2, CASP1, MAPK1, TNF
|
05205 |
Proteoglycans in cancer |
8 |
2.30E-05 |
TGFB1, CCND1, PRKCB, MYC, MMP2, MAPK1, ESR1, TNF
|
05146 |
Amoebiasis |
6 |
9.76E-05 |
IL-10, TGFB1, NOS2, PRKCB, HSPB1, TNF
|
05164 |
Influenza A |
7 |
1.05E-04 |
IL-1A, GSK3B, STAT1, PRKCB, CASP1, MAPK1, TNF
|
04380 |
Osteoclast differentiation |
6 |
2.65E-04 |
IL-1A, TGFB1, NCF1, STAT1, MAPK1, TNF
|
04010 |
MAPK signaling pathway |
7 |
7.91E-04 |
IL-1A, TGFB1, PRKCB, MYC, HSPB1, MAPK1, TNF
|